BALCHEM CORP (BCPC) Stock Price, Forecast & Analysis

USA • Nasdaq • NASDAQ:BCPC • US0576652004

173.72 USD
-0.29 (-0.17%)
At close: Feb 5, 2026
173.72 USD
0 (0%)
After Hours: 2/5/2026, 8:10:40 PM

BCPC Key Statistics, Chart & Performance

Key Statistics
Market Cap5.63B
Revenue(TTM)1.01B
Net Income(TTM)149.20M
Shares32.39M
Float32.21M
52 Week High177.4
52 Week Low139.17
Yearly Dividend0.79
Dividend Yield0.56%
EPS(TTM)4.97
PE34.95
Fwd PE30.56
Earnings (Next)02-13
IPO1986-06-03
Sector
GICS SectorMaterials
GICS IndustryChemicals
GICS IndustryGroupMaterials
GICS SubIndustrySpecialty Chemicals
BCPC short term performance overview.The bars show the price performance of BCPC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 2 4 6 8 10

BCPC long term performance overview.The bars show the price performance of BCPC in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30

The current stock price of BCPC is 173.72 USD. In the past month the price increased by 12.3%. In the past year, price increased by 8.39%.

BALCHEM CORP / BCPC Daily stock chart

BCPC Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to BCPC. When comparing the yearly performance of all stocks, BCPC is one of the better performing stocks in the market, outperforming 71.03% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

BCPC Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to BCPC. BCPC scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BCPC Financial Highlights

Over the last trailing twelve months BCPC reported a non-GAAP Earnings per Share(EPS) of 4.97. The EPS increased by 18.33% compared to the year before.


Industry RankSector Rank
PM (TTM) 14.72%
ROA 8.98%
ROE 11.5%
Debt/Equity 0.12
Chartmill High Growth Momentum
EPS Q2Q%19.47%
Sales Q2Q%11.51%
EPS 1Y (TTM)18.33%
Revenue 1Y (TTM)7.55%

BCPC Forecast & Estimates

9 analysts have analysed BCPC and the average price target is 194.82 USD. This implies a price increase of 12.15% is expected in the next year compared to the current price of 173.72.

For the next year, analysts expect an EPS growth of 19.01% and a revenue growth 8.25% for BCPC


Analysts
Analysts80
Price Target194.82 (12.15%)
EPS Next Y19.01%
Revenue Next Year8.25%

BCPC Ownership

Ownership
Inst Owners92.79%
Ins Owners0.4%
Short Float %1.08%
Short Ratio1.91

BCPC Latest News, Press Relases and Analysis

BCPC Competitors/Peers

The largest stocks on the US markets in the "Specialty Chemicals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
SHW SHERWIN-WILLIAMS CO/THE29.6591.449B
ECL ECOLAB INC33.6381.618B
PPG PPG INDUSTRIES INC15.3628.263B
DD DUPONT DE NEMOURS INC20.5220.04B
ALB ALBEMARLE CORP75.119.851B
IFF INTL FLAVORS & FRAGRANCES16.2919.026B
RPM RPM INTERNATIONAL INC1914.882B
SOLS SOLSTICE ADV MATERIALS INC21.1910.352B
EMN EASTMAN CHEMICAL CO12.868.953B
AXTA AXALTA COATING SYSTEMS LTD12.27.311B

About BCPC

Company Profile

BCPC logo image Balchem Corp. provides marketing of specialty performance ingredients and products. The company is headquartered in Montvale, New Jersey and currently employs 1,355 full-time employees. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.

Company Info

BALCHEM CORP

5 Paragon Drive

Montvale NEW JERSEY 10958 US

CEO: Theodore L. Harris

Employees: 1355

BCPC Company Website

BCPC Investor Relations

Phone: 18453265600

BALCHEM CORP / BCPC FAQ

What does BALCHEM CORP do?

Balchem Corp. provides marketing of specialty performance ingredients and products. The company is headquartered in Montvale, New Jersey and currently employs 1,355 full-time employees. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.


Can you provide the latest stock price for BALCHEM CORP?

The current stock price of BCPC is 173.72 USD. The price decreased by -0.17% in the last trading session.


Does BCPC stock pay dividends?

BALCHEM CORP (BCPC) has a dividend yield of 0.56%. The yearly dividend amount is currently 0.79.


What is the ChartMill rating of BALCHEM CORP stock?

BCPC has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


On which exchange is BCPC stock listed?

BCPC stock is listed on the Nasdaq exchange.


What is the ownership structure of BALCHEM CORP (BCPC)?

You can find the ownership structure of BALCHEM CORP (BCPC) on the Ownership tab.


What is the Short Interest ratio of BALCHEM CORP (BCPC) stock?

The outstanding short interest for BALCHEM CORP (BCPC) is 1.08% of its float.